Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Finch, GB

Andy Finch, Leicestershire GB

Patent application numberDescriptionPublished
20100288990STANCHION WITH DISPLAY DEVICE - A stanchion for use in a barrier system in accordance with an embodiment of the present application includes a display device mounted at substantially eye level such that it is easily viewed by a user waiting in line in the barrier system. The display device may include interactive features to track user position or allow users to request information, input information or to conduct transactions while on line.11-18-2010

David Finch, East Sussex GB

Patent application numberDescriptionPublished
20110193496CONTROL SYSTEMS - A lighting control system comprises an input for receiving a mains supply voltage; an output for providing an output voltage signal for powering plural lamps; a controller; a first transformer connected to the input and being for reducing the mains supply voltage to a reduced voltage; a second transformer having a secondary winding connected in series between the first transformer and the output and having a primary winding connected to the controller, the secondary and primary windings being arranged so as to induce a supplementary voltage in the secondary winding when said primary winding is energised. The controller is configured in a first phase to provide a first energising signal to the primary winding of the second transformer such as to supplement the reduced voltage provided by the first transformer, thereby to provide an output voltage signal that is greater than the reduced voltage signal; and in a second phase to short-circuit the primary winding of the second transformer, thereby to provide an output voltage signal substantially at the reduced voltage. The controller is configured in a third phase to provide a second energising signal to the primary winding of the second transformer such as to alter the reduced voltage provided by the first transformer, the second energising signal having a different voltage to the first energising signal, thereby to provide an output voltage signal in the third phase that is different to the output voltage signals provided in the first and second phases.08-11-2011
20110193497CONTROL SYSTEMS - A lighting control system comprises an input for receiving a mains supply voltage; an output for providing an output voltage signal for powering plural lamps; a controller; a first transformer connected to the input and being for reducing the mains supply voltage to a reduced voltage; a second transformer having a secondary winding connected in series between the first transformer and the output and having a primary winding connected to the controller, the secondary and primary windings being arranged so as to induce a supplementary voltage in the secondary winding when said primary winding is energised. The controller is configured in a first phase, to provide a first energising signal to the primary winding of the second transformer such as to supplement the reduced voltage provided by the first transformer, thereby to provide an output voltage signal that is greater than the reduced voltage signal and in a second phase, immediately following the first phase, to cease to provide the first energising signal to the primary winding of the second transformer, thereby to provide an output voltage signal in the second phase that is different to the output voltage signal provided in the first phase The controller includes a control input for receiving a control signal from a user, for allowing a user to configure one or more parameters of the lighting control system.08-11-2011

Derek Geoffrey Finch, Isle Of Wight GB

Patent application numberDescriptionPublished
20100169890URGENCY BASED SCHEDULING - The present invention relates to a method of scheduling for multi-function radars. Specifically, the present invention relates to an efficient urgency-based scheduling method.07-01-2010

Donna K. Finch, Newmarket GB

Patent application numberDescriptionPublished
20110008364ANTIBODIES TO TGF-BETA - The present invention relates to antibody molecules, in particular antibody molecules that bind Transforming Growth Factor beta (TGFβ), and uses thereof. More particularly, the invention relates to antibody molecules that bind and preferably neutralise TGFβ1, TGFβ2 and TGFβ3, so-called “pan-specific” antibody molecules, and uses of such antibody molecules. Preferred embodiments within the present invention are antibody molecules, whether whole antibody (e.g. IgG, such as IgG1 or IgG4) or antibody fragments (e.g. scFv, Fab, dAb).01-13-2011

Donna Kirsty Finch, Cambridgeshire GB

Patent application numberDescriptionPublished
20100221257BINDING MEMBERS-513 - This invention relates to binding members, especially antibody molecules, specific for interleukin 1 receptor 1 (IL-1R1). For example, isolated binding members specific for IL-1R1 which competes with IL-1 and IL-1Ra for binding to IL-1R1 and binds Il-1R1 with a K09-02-2010

Harry Finch, Berkshire GB

Patent application numberDescriptionPublished
20120088763TRIAZOLOPYRIDINE DERIVATIVES AND THEIR THERAPEUTIC USE - Compounds of formula (I) are inhibitors of p38 MAP kinase, useful as anti-inflammatory agents in the treatment of inter alia, diseases of the respiratory tract wherein; R04-12-2012

Harry Finch, Harlow GB

Patent application numberDescriptionPublished
20080318912Medicaments for Treating Chronic Respiratory Disease - There is provided the use of a methylxanthine compound and a steroid in a synergistic combination for the treatment of a respiratory disease, wherein the methylxanthine compound is administered at a dose, which, in isolation, is not effective to treat said disease.12-25-2008
20100324002Inhaled combination therapy - There is provided the use of a methylxanthine derivative such as theophylline and a steroid in a synergistic combination for the treatment of chronic obstructive pulmonary disease, wherein the combination is administered by the inhaled route for pulmonary delivery.12-23-2010
20110319446BICYCLO[2.2.1]HEPT-7-YLAMINE DERIVATIVES AND THEIR USES - Compounds of formula (I) have muscarinic M3 receptor modulating activity;12-29-2011

Patent applications by Harry Finch, Harlow GB

Harry Finch, Cambridge GB

Patent application numberDescriptionPublished
20100105651ANTAGONISTS OF SNS SODIUM CHANNELS - Compounds of the formula (I), and pharmaceutically acceptable salts thereof, are found to be antagonists of SNS sodium channels. They are therefore useful as analgesic and neuroprotective agents, formula (I): R04-29-2010
20100204224AZACYCLIC COMPOUNDS AS INHIBITORS OF SENSORY NEURONE SPECIFIC SODIUM CHANNELS - Compounds of the formula (I), and pharmaceutically acceptable salts thereof, are found to be antagonists of SNS sodium channels. They are therefore useful as analgesic and neuroprotective agents; wherein (1) represents (A), (B) or (C); R08-12-2010

Harry Finch, Abington GB

Patent application numberDescriptionPublished
20100179138Isozazole Compounds As Inhibitors Of Heat Shock Proteins - Isoxazoles of formula (A) or (B) are inhibitors of HSP90 activity, and useful for treatment of, for example cancers:07-15-2010

Harry Finch, Harlow Essex GB

Patent application numberDescriptionPublished
20120027692PYRROLOPYRIMIDINEDIONE AND ITS THERAPEUTIC USE - The compound of formula (I) is an inhibitor of human neutrophil elastase, useful for inhalation treatment of pulmonary inflammation.02-02-2012

Steven Caffall Finch, London GB

Patent application numberDescriptionPublished
20090090070Railway arch linings and mezzanine floors - A system for lining arched structures, particularly railway arches (04-09-2009